Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT05382845
Recruiting Not applicable

Screening for Pregnancy Related Pelvic Girdle Pain

NCT05382845 · tracked via the Priya Life Science Sweden tracker
Sponsor
Blekinge County Council Hospital
Phase
Not applicable
Started
2022-05-01
Last updated
2024-10-22

Condition(s) studied

Pelvic Girdle Pain

Investigational drug(s) / intervention(s)

Manual pain provocation tests

Manual pain provocation tests: Validated and empirical pain provocation tests of the pelvic joints will be performed, both to exclude ongoing symptoms, and to diagnose one or several dysfunctions. The participants will be asked questions regarding previous symptoms, traumas, type of profession etc.

Study summary

To perform clinical manual pain provocation tests of the pelvic joints in pain free pregnant women early in pregnancy, follow them until delivery, and compare those who develop PPGP with those who don't.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Pregnant women before gestational week 20 without any ongoing symptoms of pain from their pelvic joints. Exclusion Criteria: * Fibromyalgia * sick-leave * working at home * treatment of the pelvic joints during the pregnancy

Primary outcome measure(s)

  • Correlation between pain provocation tests, different risk factors and full time sick-leave. — Approximately six months for each participant
    Screening of symptom free pregnant women at their first visit in Maternity care using pain provocation tests of the pelvic joints, together with known risk factors for Pregnancy related Pelvic Girdle Pain (PPGP), and a plausible association with the primary outcome full time sick-leave due to PPGP.

Trial sites (1)

FacilityCityRegionStatus
The Region Hospital of Blekinge County Karlskrona Blekinge County Recruiting

More Blekinge County Council Hospital trials in Sweden

Patient Reported Outcome Measures in Umbilical Hernia Surgery Enrolling by invitation
Sleep-Disordered Breathing in the Acute Phase After Stroke and Neuropsychiatric Outcomes Starting soon

Other trials for the same condition

WOMENinMOTION An Intervention Model for Pelvic Girdle Pain Recruiting
Exploring Central Sensitization in Pregnant Women Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05382845 on ClinicalTrials.gov ↗ ← All trials in Sweden